Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q2 2020 · 10-Q
Revenue$0.00$0.00— vs Q2 2019 Net Income-$1.17M-$1.17MN/M vs Q2 2019 EPS Diluted-$0.23-$0.23N/M vs Q2 2019 Operating Income-$1,029,934N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Jun 30, 2020 · filed Aug 13, 2020 · 44 d after period end